AKLI vs. MDAI, RVP, NMTC, MODD, FEMY, LNSR, ICU, CODX, CTCX, and XAIR
Should you be buying Akili stock or one of its competitors? The main competitors of Akili include Spectral AI (MDAI), Retractable Technologies (RVP), NeuroOne Medical Technologies (NMTC), Modular Medical (MODD), Femasys (FEMY), LENSAR (LNSR), SeaStar Medical (ICU), Co-Diagnostics (CODX), Carmell (CTCX), and Beyond Air (XAIR). These companies are all part of the "surgical & medical instruments" industry.
Akili (NASDAQ:AKLI) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.
53.1% of Akili shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 10.1% of Akili shares are held by company insiders. Comparatively, 56.7% of Spectral AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Spectral AI has higher revenue and earnings than Akili.
Spectral AI has a net margin of 0.00% compared to Akili's net margin of -3,545.47%. Spectral AI's return on equity of 0.00% beat Akili's return on equity.
Akili has a beta of 1.7, suggesting that its stock price is 70% more volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500.
Akili received 5 more outperform votes than Spectral AI when rated by MarketBeat users. However, 100.00% of users gave Spectral AI an outperform vote while only 66.67% of users gave Akili an outperform vote.
In the previous week, Spectral AI had 5 more articles in the media than Akili. MarketBeat recorded 6 mentions for Spectral AI and 1 mentions for Akili. Spectral AI's average media sentiment score of 0.49 beat Akili's score of 0.00 indicating that Spectral AI is being referred to more favorably in the news media.
Akili presently has a consensus target price of $4.00, indicating a potential upside of 885.22%. Spectral AI has a consensus target price of $4.00, indicating a potential upside of 131.21%. Given Akili's higher possible upside, research analysts plainly believe Akili is more favorable than Spectral AI.
Summary
Spectral AI beats Akili on 9 of the 14 factors compared between the two stocks.
Get Akili News Delivered to You Automatically
Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AKLI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
